Clinical Trials Directory

Trials / Completed

CompletedNCT01641276

Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Hospital Sirio-Libanes · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The propose of this study is to identification of a group of specific amplitude-modulated frequencies of low intensity electromagnetic fields that is associated with biofeedback upon exposure to in patients with hepatitis B carries with or without hepatocellular carcinoma.

Detailed description

Patients will be exposed by different specific amplitude-modulated frequencies of low intensity electromagnetic fields for 30 min. During the exposure, autonomic response with be recorded in order to identify biofeedback response. Differences in group of frequencies is expected in patients with hepatitis B carries with or without hepatocellular carcinoma.

Conditions

Interventions

TypeNameDescription
DEVICELow intensity amplitude-moduled electromagnetic fieldsPatients in each arm will be exposed to 30 min of amplitude-moduled low intensity electromagnetic fields only one time.

Timeline

Start date
2012-04-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2012-07-16
Last updated
2015-09-14

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01641276. Inclusion in this directory is not an endorsement.